TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Fujirebio Diagnostics AB
Closing information (x1000 EUR)
Closing information | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
Turnover | 25,645 | 24,441 | |
Financial expenses | 46 | 2,854 | |
Earnings before taxes | 13,481 | 9,826 | |
EBITDA | 14,000 | 13,125 | |
Total assets | 59,513 | 45,434 | |
Current assets | 28,726 | 38,887 | |
Current liabilities | 6,148 | 2,760 | |
Equity capital | 52,719 | 42,156 | |
- share capital | 62 | 63 | |
Employees (average) | 86 | 75 | 71 |
Financial ratios
Fiscal year | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
Solvency | 88.6% | 92.8% | |
Turnover per employee | 342 | 344 | |
Profit as a percentage of turnover | 52.6% | 40.2% | |
Return on assets (ROA) | 22.7% | 27.9% | |
Current ratio | 467.2% | 1408.9% | |
Return on equity (ROE) | 25.6% | 23.3% | |
Change turnover | 1,442 | -2,464 | |
Change turnover % | 17% | 6% | -9% |
Chg. No. of employees | 11 | 4 | 4 |
Chg. No. of employees % | 15% | 6% | 6% |
Total value of public sale
Fiscal year | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.